Analysis of Whole-Brain Resting-State MRI Using Multi-Label Deformable Offset Networks and Segmentations Based Attention with Explorations into the Ethical Implications of Artificial Intelligence in Clinical Psychiatry Settings and Care
View/ Open
Date
2022Author
Agarwal, Vatsal
Ayoroa, Evan
Burdick, Ryerson
Ganeshan, Aravind
Paliyam, Madhava
Wood, Sam
Lee, Caitlin
Akhtarkhavari, Sepehr
Inala, Shika
Matharu, Sagar
Mupparapu, Neelesh
Advisor
Deane, Anil
DRUM DOI
Metadata
Show full item recordAbstract
Due to the poor understanding of the underlying biological mechanisms of psychiatric
disorders, diagnoses rely upon symptomatic criteria and clinicians’ discretion. Reviews of these
criteria have revealed issues of heterogeneity, over and under specificity, and symptom overlap
between disorders. Deep learning provides a method to produce quantifiable diagnostic labels
based upon biological markers such as specific features of brain anatomy or functionality. In
practice, these methods fail to indicate how a particular result was determined, raising major
obstacles for clinical implementation.To improve the efficiency and interpretability of existing
deep networks, we have developed a novel atlas-based attention module to more easily capture
global information across different areas of brain function. Our model can be extended to
symptom level classification using NIMH data to give clinicians usable information outside of
broad disorder classification. We have compared our model against leading 3D deep learning
frameworks and have shown that our novel atlas-based attention module achieves 88% F1 and
91% accuracy on the UCLA Consortium for Neuropsychiatric Phenomics dataset. We have
embedded our model with elements like deformable convolutions, gradient activation
visualizations, and occlusion testing to show model attention and function. In addition to the lack
of explainability, addressing the ethical issues surrounding clinical implementation of artificial
intelligence is necessary before usage can become a reality. We identified a series of regulatory
recommendations to address pertinent ethical concerns of equity and bias during both model
development and clinical usage. We propose a standardized protocol for developing a clinical
reference standard, the development of diversity reports regarding data used by models, and
regulation of usage scenarios to reduce contextual bias.
Notes
Gemstone Team MIND